Revenue
2009
2010
2011
2012
2013
FILANA THERAPEUTICS, INC. (FLNA)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2019
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | — | — | — | $41.1M | $10.9M | $11.5M | $16.8M | $20.6M |
| Research & development | $26.6M | $69.6M | $89.4M | $68.0M | $24.8M | — | — | $3.0M | $7.6M | $9.2M | $9.1M | $7.3M | $4.9M | $7.6M | $8.3M | $15.7M | $21.1M |
| Operating expenses | $95.4M | $141.4M | $106.0M | $80.0M | $32.9M | $6.4M | $5.0M | $6.7M | $11.9M | $15.0M | $14.2M | $12.4M | $9.8M | $14.8M | $15.0M | $30.5M | $27.3M |
| Operating income | −$95.4M | −$141.4M | −$106.0M | −$80.0M | −$32.9M | −$6.4M | −$5.0M | −$6.7M | −$11.9M | −$15.0M | −$14.2M | −$12.4M | $31.4M | −$3.9M | −$3.5M | −$13.7M | −$6.8M |
| EBITDAderived | −$94.5M | −$140.3M | −$104.4M | −$78.7M | −$32.3M | −$6.4M | −$4.9M | −$6.6M | −$11.9M | −$14.9M | −$14.2M | −$12.4M | — | −$3.8M | −$3.4M | −$13.5M | −$6.5M |
| Net income | −$91.0M | −$24.3M | −$97.2M | −$76.2M | −$32.4M | −$6.3M | −$4.6M | −$6.6M | −$11.9M | −$14.8M | −$14.1M | −$12.4M | $31.5M | −$3.4M | −$2.6M | −$12.0M | −$3.5M |
| Basic EPSper diluted share | -$1.88 | -$0.53 | -$2.32 | -$1.90 | -$0.82 | -$0.24 | -$0.27 | -$0.61 | -$1.82 | -$2.28 | -$0.31 | -$0.27 | $0.70 | -$0.08 | -$0.06 | -$0.28 | -$0.08 |
| Diluted EPSper diluted share | -$1.88 | -$1.46 | -$2.32 | -$1.90 | -$0.82 | -$0.24 | -$0.27 | -$0.61 | -$1.82 | -$2.28 | -$0.31 | -$0.27 | $0.70 | -$0.08 | -$0.06 | -$0.28 | -$0.08 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Nov 24, 2025Form 4 | Anderson Robert Eugene JrDirector | BuyCommon Stock | 8.6K | $2.90 | $24.9K | 8.6K |
| Nov 20, 2025Form 4 | Barry RichardPresident & CEO | BuyCommon Stock · indirect | 150.0K | $2.76 | $414.0K | 938.1K |
| Nov 19, 2025Form 4 | Barry RichardPresident & CEO | BuyCommon Stock · indirect | 73.4K | $2.75 | $201.8K | 788.1K |
| Sep 30, 2025Form 4 | Cook Robert ChristopherChief Operating & Legal Office | BuyCommon Stock | 13.7K | $2.91 | $39.9K | 13.7K |
| Sep 22, 2025Form 4 | Barry RichardPresident & CEO | BuyCommon Stock · indirect | 7.2K | $2.28 | $16.4K | 714.7K |